CCL26 and cancer: While previous studies have offered preliminary insights into the role of CCL26 in specific cancers, targeting chemokines and their receptors has been proposed as a promising strategy for immunotherapy (Qin et al., 2023), its broader implications in the realm of immunotherapy across OSCC remain unknown.